Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Sep 26 - Oct 1
Usharani P, Nutalapati C, Pokuri VK, Kumar CU, Taduri G
It is considered an investigational compound and is typically sold by research chemical suppliers under the label for research purposes only
Escobar, J
Food and Drug Administration (FDA) and the European Medicines Agency (EMA) treat it as an unapproved substance
A Phase 3, Multicenter, Randomized, Double-blind, Active-controlled, Parallel-group Trial With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Oral E5501 Versus Eltrombopag, in Adults With Chronic Immune Thrombocytopenia (Idiopathic Thrombocytopenic Purpura)
Recovery Because peptide therapy is minimally invasive and self-administered at home , there is no downtime or recovery required
US$ 20.55
US$ 25.57
US$ 24.32
US$ 24.93
US$ 25.95
